220 related articles for article (PubMed ID: 31446540)
1. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study.
Yongchairat K; Tanboon J; Waisayarat J; Narongroeknawin P; Chevaisrakul P; Dejthevaporn C; Katchamart W
Clin Rheumatol; 2019 Dec; 38(12):3459-3469. PubMed ID: 31446540
[TBL] [Abstract][Full Text] [Related]
2. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy.
Kruse RL; Albayda J; Vozniak SO; Lawrence CE; Goel R; Lokhandwala PM; Ness PM; Tobian AAR; Bloch EM; Crowe EP
J Clin Apher; 2022 Jun; 37(3):253-262. PubMed ID: 35119135
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and pathological characteristics of immune mediated necrotizing myopathy].
Yang HX; Tian XL; Jiang W; Li WL; Liu QY; Peng QL; Wang GC; Lu X
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):989-995. PubMed ID: 31848492
[TBL] [Abstract][Full Text] [Related]
5. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
Basharat P; Christopher-Stine L
Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
[TBL] [Abstract][Full Text] [Related]
6. Necrotizing Autoimmune Myopathy: A Unique Subset of Idiopathic Inflammatory Myopathy.
Carroll MB; Newkirk MR; Sumner NS
J Clin Rheumatol; 2016 Oct; 22(7):376-80. PubMed ID: 27660937
[TBL] [Abstract][Full Text] [Related]
7. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
[No Abstract] [Full Text] [Related]
8. Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.
Yang H; Peng Q; Yin L; Li S; Shi J; Zhang Y; Lu X; Shu X; Zhang S; Wang G
Arthritis Res Ther; 2017 Nov; 19(1):259. PubMed ID: 29178913
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy in necrotizing autoimmune myopathy associated with anti-SRP antibody: A clinical case review.
Nóvoa Medina FJ; Gutiérrez Martínez J; González González Y; Romero Díaz B; Machín García S; Rosas Romero A
Reumatol Clin (Engl Ed); 2018; 14(6):379-381. PubMed ID: 28389200
[TBL] [Abstract][Full Text] [Related]
11. Necrotizing Autoimmune Myopathy: Clinicopathologic Study from a Single Tertiary Care Centre.
Ayesha SM; Meena AK; Vangala N; Rajasekhar L; Kaul S; Borgahain R; Uppin MS
Ann Indian Acad Neurol; 2018; 21(1):62-67. PubMed ID: 29720800
[TBL] [Abstract][Full Text] [Related]
12. Acquired necrotizing myopathies.
Allenbach Y; Benveniste O
Curr Opin Neurol; 2013 Oct; 26(5):554-60. PubMed ID: 23995277
[TBL] [Abstract][Full Text] [Related]
13. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
14. Revisiting Pathological Classification Criteria for Adult Idiopathic Inflammatory Myopathies: In-Depth Analysis of Muscle Biopsies and Correlation Between Pathological Diagnosis and Clinical Manifestations.
Hou Y; Luo YB; Dai T; Shao K; Li W; Zhao Y; Lu JQ; Yan C
J Neuropathol Exp Neurol; 2018 May; 77(5):395-404. PubMed ID: 29522204
[TBL] [Abstract][Full Text] [Related]
15. [Clinical and immunological characteristics of 88 cases of overlap myositis].
Xiao YS; Zhu FY; Luo L; Xing XY; Li YH; Zhang XW; Shen DH
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1088-1093. PubMed ID: 34916687
[TBL] [Abstract][Full Text] [Related]
16. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategy in inflammatory myopathies (polymyositis, dermatomyositis, overlap myositis, and immune-mediated necrotizing myopathy)].
Tournadre A
Rev Med Interne; 2014 Jul; 35(7):466-71. PubMed ID: 24144868
[TBL] [Abstract][Full Text] [Related]
18. Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies.
Hengstman GJ; Brouwer R; Egberts WT; Seelig HP; Jongen PJ; van Venrooij WJ; van Engelen BG
J Neurol; 2002 Jan; 249(1):69-75. PubMed ID: 11954871
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
Dourmishev LA
Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and classification of idiopathic inflammatory myopathies.
Lundberg IE; Miller FW; Tjärnlund A; Bottai M
J Intern Med; 2016 Jul; 280(1):39-51. PubMed ID: 27320359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
